Dharti Proteins Q2 Results, Bonus Share Consideration

The Board of Directors meeting is scheduled to be held on Tuesday, 13th October, 2026. The agenda for the meeting includes:

• Consideration, discussion, and approval of the Audited Standalone Financial Results of the Company for the second quarter and half year ended 30th September, 2026. The board will also take on record the Interim Audit Report thereon.

• Consideration of the proposal for issue of bonus shares to the public shareholders of the Company. The purpose of this bonus share issuance is to achieve compliance with the Minimum Public Shareholding requirements mandated under rule 19A of the Securities Contracts (Regulation) Rules, 1957 read with regulation 38 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015.

• Consideration of any other matter with the permission of the chair.

The disclosure is addressed to The General Manager, Listing Department, BSE Limited at Pheeroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001, Maharashtra, India. The company's symbol is DHARTI and ISIN is INE248C01021.

The letter is signed by Twinkle Bipinchandra Gajjar, Company Secretary and Compliance Officer (ICSI Membership No. A77101).